Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00411567
Status:
COMPLETED
Last Update Posted:
2007-06-22
First Post:
2006-12-13
Brief Title:
A Study to Assess the Efficacy of Inhaled Corticosteroid ICS Therapy in Moderate-Severe Bronchial Asthma
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
An Open Label Study to Assess the Utility of Measuring Markers of Inflammation to Detect Transition From Optimal to Sub-Optimal Inhaled Corticosteroid Therapy in Moderate-Severe Bronchial Asthma
Status:
COMPLETED
Status Verified Date:
2007-06
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to investigateassess the treatment of moderate to severe asthmatics with inhaled corticosteroid
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None